Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine
Historical observation
20182026
Universe›Health Care›Biotechnology›Biotechnology
Biotechnology · weight
2.50%
Industry change · 12M
-0.59 pp
Biotechnology · contribution
-0.587 pp
Company participation
86%
of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Apr 2019 · sorted by absolute contribution to 12-month change

CompanyCountryMarket capUniverse weight3M contribution12M contribution12M price returnAbove 6M weight average
AbbVie →
ABBV
United States$117.1bn0.652%+0.254 pp-0.290 pp-13.9%Yes
Gilead Sciences →
GILD
United States$83.0bn0.462%+0.164 pp-0.119 pp-6.9%Yes
Biogen →
BIIB
United States$44.4bn0.248%+0.026 pp-0.107 pp-16.2%No
Amgen →
AMGN
United States$111.6bn0.622%+0.229 pp-0.088 pp+5.8%Yes
Incyte →
INCY
United States$16.5bn0.092%+0.035 pp+0.011 pp+24.0%Yes
Regeneron Pharmaceuticals →
REGN
United States$32.2bn0.180%+0.047 pp+0.004 pp+13.0%Yes
Vertex Pharmaceuticals →
VRTX
United States$43.2bn0.241%+0.080 pp+0.001 pp+10.3%Yes

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.